RACHEL PIERCE: Open Payments
NPI 1609412634 · GROSSE POINTE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,136 in 45 payments from 12 companies in 2025. Trend: 2023 $1,350 · 2024 $1,186 · 2025 $1,136
Food & beverage: $1,136
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $482 |
| Gilead Sciences, Inc. | 8 | $227 |
| PFIZER INC. | 8 | $130 |
| Regeneron Healthcare Solutions, Inc. | 3 | $68 |
| Lilly USA, LLC | 3 | $51 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $45 |
| Mirum Pharmaceuticals, Inc. | 1 | $27 |
| Sandoz Inc. | 1 | $25 |
| GENZYME CORPORATION | 1 | $25 |
| Intercept Pharmaceuticals, Inc. | 1 | $20 |
Products named: SKYRIZI, RINVOQ, XELJANZ, DUPIXENT, LINZESS, CREON, ENTYVIO, OMVOH.
Industry payments across MI — which companies pay providers there.
